0 items USD 0.00Search
- Did you mean
- psoriasis arthrex
Your search for "Psoriatic arthritis" gave back 697 results.
The global Psoriatic Arthritis Treatment market is projected to reach US$ 12040 million in 2029, increasing from US$ 7910.7 million in 2022, with the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Highlights The global Psoriatic Arthritis Treatment Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Highlights The global Psoriatic Arthritis (PsA) Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Summary HeyReport estimates that the Musculoskeletal Disorders Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025,...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Summary The Musculoskeletal Disorders Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%...
Catalog:
HYR
March 2021
Price: USD 2,000.00
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Treatment of drugs for regulating rheumatic diseases The “Rheumatic Disorders Drug Industry Forecast” looks at past sales and reviews total world...
Catalog:
LPI
March 2023
Price: USD 3,660.00
